S. Metzger

发表

Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial

B. Fervers, J. Carretier, A. Foucaut, 2019, Supportive Care in Cancer.

Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso‐occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study

M. Morelle, S. Chabaud, S. Thouvenin, 2018, Pain practice : the official journal of World Institute of Pain.

A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma.

J. Blay, L. Brugières, D. Pérol, 2019, European journal of cancer.

Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).

C. Sire, P. Fournel, Y. Tao, 2022, European journal of cancer.

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.

J. Blay, M. Toulmonde, A. Italiano, 2018, The Lancet. Oncology.

BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres†

F. Jardin, O. Casasnovas, D. Pérol, 2021, British journal of haematology.

Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT.

J. Blay, A. Italiano, A. Le Cesne, 2022, European journal of cancer.

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

J. Soria, B. Escudier, D. Pérol, 2017, BMC Cancer.

Pazopanib (P) and bevacizumab (B) in patients with metastatic renal cell carcinoma (mRCC) or other advanced refractory tumors: Phase I combination study final analysis.

J. Soria, D. Pérol, A. Hollebecque, 2013 .

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

J. Soria, D. Pérol, A. Hollebecque, 2017, BMC Cancer.

Cicaderma® in radiation–related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT

A. Arnaud, D. Pérol, Y. Kirova, 2023, Clinical and translational radiation oncology.

Intra-operative High-Intensity Focused Ultrasound in Patients With Colorectal Liver Metastases: A Prospective Ablate-and-Resect Study.

A. Dupré, D. Melodelima, D. Pérol, 2023, Ultrasound in medicine & biology.